Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 164

CHAPTER 8: BIBLIOGRAPHY

1. Yang YH, Rajaiah R, Lee DY, Zhongze M, Harry HY, Fong HS, Leo L, Berman BM,

Moudigl KD. Suppression of ongoing experimental arthritis by a Chines herbal

formula (Huo-Luo- Xiao-Ling Dan) involves changes in antigen-induced

immunological and biochemical mediators of inflammation. Evid Based Complement

Alternat Med. 2011; 1-10.

2. Kehlen A, Pachnio A, Thiele K, Langner J. Gene expression induced by interleukin-17

in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of

hyaluronan-binding protein TSG-6. Arthritis Res Ther. 2003; 5(4):186-92.

3. Spector TD. Rheumatoid arthritis. Rheum Dis Clin North Am. 1990; 16(3):513-37.

4. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis

Res. 2002; 4(3):265-72.

5. Herman CJ, Allen P, Hunt WC, Prasad A, Brady TJ. Use of complementary therapies

among primary care clinic patients with arthritis. Prev Chronic Dis. 2004; 1(4):1-12.

6. Schwartzman S, Fleischmann R, Morgan JG. Do anti-TNF agents have equal efficacy

in patients with rheumatoid arthritis. Arthritis Res Ther. 2004; 6(2):3-11.

7. Axford SJ. Joint and bone infections. Rehum Int J. 2006; 34(10):405-12.

8. Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis:

pathogenetic and clinical consideration. Clin Microbiol Rev. 2004; 17(2):348-69.

9. Veihelmann A, Hofbauer A, Krombach F, Dorger M, Maier M, Refior HJ et al.

Differential function of nitric oxide in murine antigen-induced arthritis. Rheumatology

(Oxford). 2002; 41(5):509-17.

10. Calvino B, Crepon-Bernard MO, Bars D. Parallel clinical and behavioural studies of

adjuvant-induced arthritis in the rat: possible relationship with chronic pain. Behav

Brain Res. 1987; 24(1):11-29.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 165

11. Ahamed S, Anuntiyo J, Malemud CJ, Haqqi TM. Biological basis for the use of

botanicals in osteoarthritis and rheumatoid arthritis; A Review. Evid Based

Complement Alternat Med. 2005; 2(3):301–8.

12. Strand V, Kimberly R, Isaacs JD. Biologic therapies in rheumatology: lessons learned,

future directions. Nat Rev Drug Discov. 2007; 6(1):75-92.

13. Zhang RX, Fan AY, Zhou AN, Moudgil KD, Ma ZZ, Lee DY et al. Extract of the

Chinese herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant arthritis in rats. J

Ethnopharmacol. 2009; 121(3):366-71.

14. The Ayurvedic Pharmacopoeia: A Dictionary of Indian Raw Materials and Industrial

product. CSIR: New Delhi; 1998. vol 4. p. 43-50.

15. Kapoor LD. Hand book of ayurvedic medicinal plants. New York: CRS Press; 2005. p.

1130-31.

16. Sharma PV. Dravyaguna-Vijana. Varanasi: Chaukhambha Bharati Academy; 2001. p.

295.

17. Loboa R, Prabhua SK, Dr Shirwaikara A, Shirwaikara A. Curcuma zedoaria Rosc.

(white turmeric) A review of its chemical pharmacological and ethnomedicinal

properties. J Pharm pharmacol. 2009; 61(1):13-21.

18. Wilsion E, Rajamanickam GV, Vyas N, Agarwal A, Dubey GP. Herbs used in siddha

medicine for arthritis - A Review. Ind. J. Trad. Knowl. 2007; 6(4):678-86.

19. FanY, Lao, Zhang R, Zhaou A, Berman BM, Barnes. Preclinical safety and evaluation

of the aqueous acetone extract of Chinies herbal formula modified Huo Luo Xiao

Ling dan. J Chines Interg Med. 2010; 8(5):438-47.

20. Funk JL, Frye JB, Oyarzo JN, Kuscuoglu N, Wilson J, McCaffrey G et al. Efficacy

and mechanism of action of turmeric supplements in the treatment of experimental

arthritis. Arthritis Rheum. 2006; 54(11):3452-64.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 166

21. Santosh KS, Manoj KP, Bokyung S, Kwang SA, Akira M, Gautam S et al. Curcumin,

demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones

differentially regulate anti-inflammatory and anti-proliferative responses through a

through a ROS-independent mechanism. Carcinogenesis. 2007; 28(8):1765–73.

22. Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of

Curcuma longa a review of preclinical and clinical research. Altern Med Rev. 2009;

14(2):141-53.

23. Fulvio D, Acquisto J, Michael M, Sankar G. Inhibition of nuclear factor kappa B (NF-

KB) an emerging theam in anti-inflammatory therapies. Mol Inter. 2002; 2(1):22-35.

24. Delas HB, Hortelano S. Molecular basis of the anti-inflammatory effects of terpenoids.

Inflamm Allergy Drug Targets. 2009; 8(1):28-39.

25. U.S. Food and Drug administration. Guidance for Industry, Clinical development

program for drug, device and biological products for the treatment of rheumatoid

arthritis. [Online] 2006 [cited 2006 Nov]. Available from:

URL:htt://www.fda.gov/eder/guidance/index.htm

26. Henson EC, Brunson JG. Studies of adjuvant-induced arthritis in the albino rat (CFN

strain). Ann Rheum Dis. 1970; 29(2):185-89.

27. Mcdougall JJ, Karimian SM, Ferrell WR. Prolonged alteration of vasoconstrictor and

vasodilator responses in rat knee joints by adjuvant monoarthritis. Exp Physiol. 1995;

80(3):349-57.

28. Andersen ML, Santos EH, Seabra ML, Silva AA, Tufik S. Evaluation of acute and

chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced

arthritis in rats. J Ethnopharmacol. 2004; 91(2-3):325-30.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 167

29. Pezet S, Onte B,´ Gae N, Grannec I, Calvino B. Chronic Pain is Associated with

Increased TrkA Immunoreactivity in Spinoreticular Neurons. J Neurosci. 1999;

19(13):5482-92.

30. Bolon B, Campagnuolo G, Feige U. Duration of bone protection by a single

osteoprotegerin injection in rats with adjuvant-induced arthritis. Cell Mol Life Sci.

2002; 59(9):1569-76.

31. Kim EY, Moudgil KD. The determinants of susceptibility-resistance to adjuvant

arthritis in rats. Arthritis Res Ther. 2009; 11(4):239.

32. Kilimozhi D, Parthasarathy V, Amuthavalli N. Effect of Clerodendrum phlomidis on

adjuvant induced arthritis in rats - A radiographic densitometric analysis. Int J.

PharmTech Res. 2009; 1(4):1434-41.

33. Boettger MK, Leuchtweis J, Schaible HJ, Schmidt M. Videoradiographic analysis of

the range of motion in unilateral experimental knee joint arthritis in rats. Arthritis Res

Threp. 2011; 13(79):2-11

34. King RW. Rheumatoid Arthritis [Online]. 2006 [Cited 2006 Jul 13]. Available from:

URL:http://en.wikipedia.org/wiki

35. Beers MH, Berkow Rs, The Merk Manual of Diagnosis and Therapy. 7th

ed. USA:

Merck, Research Laboratories Pvt Ltd; 1999. p. 407–23.

36. Joseph TD, Robert LT, Gary CY, Gary RM, Barbara GW, Michael PL.

Pharmacotherapy-A Pathophysiologic Approach. 6th ed. New Delhi: McGraw-Hill

Medical Publication Division; 2005. p. 342-46.

37. Walker R, Edwards C. Clinical Pharmacy and Therapeutics. 5th ed. New York:

Churchill Living Stone; 2003. p. 779-96.

38. Kumar V, Dhingra S, Parle M. Rheumatoid Arthritis at a glance. Pharma Times. 2005;

37(11):53-55.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 168

39. Brunton LL, Lazo JS, Parker KL. The pharmacological basis of therapeutics. 11th ed.

New Delhi: McGrawHill medical publication division; 2006: p. 683-86.

40. Vogel HG, Vogel WH. Drug discovery and evaluation: Pharmacological assay. 3rd

ed. New York: springer-verlag Berlin Heidel berg; 2008. p. 1103-06.

41. Glynn LE. Pathology, pathogenesis, and aetiology of rheumatoid arthritis. Ann

Rheum Dis. 1972; 31(5): 412-20.

42. Kumar V, Abbas AK, Fausto N. Robbins and Cortran pathologic basis of disease. 7th

ed. Philadelphia: Saunders an imprint of elsevier; 2004. p. 1306-08.

43. Joan M, Bathon MD. Rheumatoid Arthritis Pathophysiology. Available from:

www.hopkins-arthritis.org.

44. Dayer JM, Fenner H. The role of cytokines and their inhibitors in arthritis. Baillieres

Clin Rheumatol. 1992; 6(2):485-516.

45. Masters SL, Simon A, Aksentijevich I, Kastner DL. autoinflammaticus: the molecular

pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009; 27:621-68.

46. Liu YL, Lin HM, Zou R, Wu JC, Han R, Raymond LN, at al. Suppression of complete

Freund's adjuvant-induced adjuvant arthritis by cobratoxin. Acta Pharmacol Sin. 2009;

30(2):219-27.

47. Hugh MD. A new model for rheumatoid arthritis?. Arthritis Res. 2000; 2:85–89.

48. Wang D, Miller SC, Sima M, Parker D, Buswell H, Goodrich KC et al. The

arthrotropism of macromolecules in adjuvant-induced arthritis rat model: a preliminary

study. Pharm Res. 2004; 21(10):1741-49.

49. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The

American Rheumatism Association 1987 revised criteria for the classification of

rheumatoid arthritis. Arthritis Rheum. 1988; 31(3):315-24.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 169

50. Daniel A, Neogi T, SilmanAJ, Funovits J, Felson DT, Bingham CO et al. 2010

Rheumatoid arthritis classification criteria. Artthritis rheum. 2010; 62(9):2569-81.

51. Symmons DP. Classification criteria for rheumatoid arthritis--time to abandon

rheumatoid factor. Rheumatology (Oxford). 2007; 46(5):725-26.

52. American College of Rheumatology Subcommittee on Rheumatoid Arthritis

Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update.

Arthritis Rheum. 2002; 46(2):328-46.

53. Rindfleisch JA, Muller D. Diagnosis and management of rheumatoid arthritis. Am

Fam Physician. 2005; 72(6):1037-47.

54. Management of Early Rheumatoid Arthritis [Online] 2006 [cited 2006 July13].

Available from: URL:http;//www.sign.ac.uk

55. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close

DR et al. Efficacy of B-cell-targeted therapy with rituximab in patients with

rheumatoid arthritis. N Engl J Med. 2004; 350(25):2572-81.

56. Chatzidionysiou K, Van RF. When to initiate and discontinue biologic treatments for

rheumatoid arthritis?. J Int Med. 2011; 269(6): 614-25.

57. McCulloch CA, Downey GP, El-Gabalawy H. Signalling platforms that modulate the

inflammatory response: new targets for drug development. Nat Rev Drug Discov. 2006;

5(10):864-76.

58. Rang HP, Dale MM, Ritter JM, Flower RJ. Pharmacology. 6th ed. London: Churchill

Livingstone; 2003. p. 226-45.

59. Llamas KA, Tropical flowering plants, a guide to identification and cultivation. New

York: Timber Press; 2003. p. 367.

60. Balfour IB, Thaxter R, Blackman VH. Annals of botany. London: HighWire Press;

1956. vol 84. p. 413-15.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 170

61. Wilson B, Abraham G, Manju VS, Mathew M, Vimala B, Sundaresan S, Nambisan B.

Antimicrobial activity of Curcuma zedoaria and Curcuma malabarica tubers. J

Ethnopharmacol. 2005; 99(1):147-51

62. Yonzon, Minoba, Lee, Dong J, Yokochi, Toshihiro, Kawano, Yasuhiro, Nakahara.

Antimicrobial Activities of Essential Oils of Nepal. J Essential Oil Res. 2005; 17:107–

11.

63. Uechi S, Ishimine Y, Hongo F. Antibacterial activity of essential oil derived from

Curcuma sp. (Zingiberaceae) against food borne pathogenic bacteria and its heat-

stability. Sci Bull Faculty Agric. 2000; 47:129–36.

64. Bugno A. Antimicrobial efficacy of Curcuma zedoaria extract as assessed by linear

regression compared with commercial mouthrinses. Braz J Microbiol. 2007; 38:440–

45.

65. Ficker CE, Smith ML, Susiarti S, Leaman DJ, Irawati C, Arnason JT. Inhibition of

human pathogenic fungi by members of Zingiberaceae used by the Kenyah

(Indonesian Borneo). J Ethnopharmacol. 2003; 85(2-3):289-93.

66. Ansari MH, Ahmad S. Screening of some medicinal plants for antiamoebic action.

Fitoterapia. 1991; 62(2):171–75.

67. Champakaew D, Choochote W, Pongpaibul Y, Chaithong U, Jitpakdi A, Tuetun B et

al. Larvicidal efficacy and biological stability of a botanical natural product, zedoary

oil-impregnated sand granules, against Aedes aegypti (Diptera, Culicidae). Parasitol

Res. 2007; 100(4):729-37.

68. Navarro Dde F, Souza MM, Neto RA, Golin V, Niero R, Yunes RA. Phytochemical

analysis and analgesic properties of Curcuma zedoaria grown in Brazil.

Phytomedicine. 2002; 9(5):427-32.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 171

69. Matsuda H, Morikawa T, Toguchida I, Ninomiya K, Yoshikawa M. Inhibitors of nitric

oxide production and new sesquiterpenes, zedoarofuran, 4-epicurcumenol,

neocurcumenol, gajutsulactones A and B, and zedoarolides A and B, from Zedoariae

rhizome. Chem Pharm Bull (Tokyo). 2001; 49(12):1558-66.

70. Matsuda H, Tewtrakul S, Morikawa T, Nakamura A, Yoshikawa M. Anti-allergic

principles from Thai zedoary: structural requirements of curcuminoids for inhibition of

degranulation and effect on the release of TNF-alpha and IL-4 in RBL-2H3 cells. Org

Med Chem. 2004; 12(22):5891-98.

71. Raghuveer GPS, Md Majed A, Eranna D, Ramachandrasetty S. Evaluation of anti-

ulcer effect of root of Curcuma zedoaria in rats. Ind. J. Trad. Knowl. 2003; 2(1):375–

77.

72. Han BH. Screening of the inhibitory effect of herbal medicines on the platelet

activating factor (PAF) binding: 35 selected herbal medicines based on folk medicinal

informations. Yakhak Hoeji. 1995; 39:10–13.

73. Kim DI, Lee TK, Jang TH, Kim CH. The inhibitory effect of a Korean herbal medicine,

Zedoariae rhizoma, on growth of cultured human hepatic myofibroblast cells. Life Sci.

2005; 77(8):890-906.

74. Daduang S, Sattayasai N, Sattayasai J, Tophrom P, Thammathaworn A, Chaveerach

A, et al. Screening of plants containing Naja naja siamensis cobra venom inhibitory

activity using modified ELISA technique. Anal Biochem. 2005; 341(2):316-25.

75. Sangvanich P, Kaeothip S, Srisomsap C, Thiptara P, Petsom A, Boonmee A, Svasti J.

Hemagglutinating activity of Curcuma plants. Fitoterapia. 2007; 78(1):29-31.

76. Lee H, Lin JY. Anti-mutagenic activity of extracts from anticancer drugs in Chinese

medicine. Mutat Res. 1988; 204(2):229-34.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 172

77. Athima S, Arunporn I, Chawaboon D, Chatchai W, Niwat K, Pranee R. Cytotoxic

activity of thaimedicinal plants for cancer treatment. Songklanakarin J. Sci. Technol.

2005; 27(2):469-78.

78. Myoungae K. Cytotoxic activity of the extracts from Curcuma zedoaria. J Toxicol

Public Health. 2003; 19:293–96.

79. Matthes HW. Cytotoxic components of Zingiber zerumbet, Curcuma zedoaria and C.

domestica. Phytochemistry. 1980; 19:2643–50.

80. Mau JL. Composition and antioxidant activity of the essential oil from Curcuma

zedoaria. Food Chem. 2003; 82:583-91.

81. Nadkarni KM. Indian Materia Medica. Mumbai: Popular Prakashan Private Limited; 1999.

p. 418-19.

82. Makabe H, Maru N, Kuwabara A, Kamo T, Hirota M. Anti-inflammatory sesquiterpenes

from Curcuma zedoaria. Nat Prod Res. 2006; 20(7):680-85.

83. Ma X, Yu X, Han J. Application of off-line supercritical fluid extraction-gas

chromatography for the investigation of chemical constituents in Curcuma zedoaria.

Phytochem Anal. 1995; 6(6): 292-96.

84. Christiane RP. Seasonal variation and analgesic properties of different parts from

Curcuma zedoaria Roscoe (Zingiberaceae) grown in Brazil. J Natur forsch. 2006;

61:6–10.

85. Jang MK, Lee HJ, Kim JS, Ryu JH. A curcuminoid and two sesquiterpenoids from

Curcuma zedoaria as inhibitors of nitric oxide synthesis in activated macrophages.

Arch Pharm Res. 2004 Dec; 27(12):1220-25

86. Takano I, Yasuda I, Takeya K, Itokawa H. Guaiane sesquiterpene lactones from

Curcuma aeruginosa. Phytochemistry. 1995; 40(4):1197-1200.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 173

87. Shiobara Y, Asakawa Y, Kodama M, Takemoto T. 13-hydroxygermacrone and

curzeone, three sesquiterpenoids from Curcuma zedoaria. Phytochemistry. 1986 Sept;

25(6): 1351-53.

88. Gupta SK, Banerjee AB, Achari B. Isolation of Ethyl p-methoxycinnamate, the major

antifungal principle of Curcumba zedoaria. Lloydia. 1976; 39(4):218-22.

89. Hong CH, Kim Y, Lee SK. Sesquiterpenoids from the rhizome of Curcuma zedoaria.

Arch Pharm Res. 2001; 24(5):424-26.

90. Mau JL. Composition and antioxidant activity of the essential oil from Curcuma

zedoaria. Food Chem. 2003; 82(4):583-91.

91. Singh G, Om PS, Sumitra M. Chemical and biocidal investigations on essential oils of

some Indian Curcuma species. Progress in Crystal Growth and Characterization of

Materials. J. Sci Food Agri. 2002; 45(1-2):75–81.

92. Garg SN, Naquvi AA, Bansal RP, Bahl J R, Kumar S. Chemical composition of the

essential oil from the leaves of Curcuma zedoaria Rosc of Indian origin. J Essen oil

Res. 2005; 17:29-31.

93. Tohda C, Nakayama N, Hatanaka F, Komatsu K. Comparison of Anti-inflammatory

Activities of Six Curcuma Rhizomes: A Possible Curcuminoid-independent Pathway

Mediated by Curcuma phaeocaulis Extract. Evid Based Complement Alternat

Med. 2006; 3(2):255-60.

94. Purkayastha J, Subhan CN, Klinkby N. Essential oil of the rhizome of Curcuma

zedoaria (Christm) Rosc Native to northeast India. J Esse oil Res. 2006; 18:154–55.

95. Ozaki Y. Anti-inflammatory effect of Curcuma xanthorrhiza Roxb., and its active

principles. Chem Pharm Bull. 1990; 38:1045-48.

96. Paramapojn S, Gritsanapan W. Variation of curcuminoid in ethanolic extract of

Curcuma zedoaria rhizomes in Thailand by HPLC. Planta Medica. 2007; 73:797-804.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 174

97. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB.

Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene

expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999;

163(6):3474- 83.

98. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": from kitchen

to clinic. Biochem Pharmacol. 2008; 75(4):787-809.

99. Abe Y, Hashimoto S, Horie T. Curcumin inhibition of inflammatory cytokine

production by human peripheral blood monocytes and alveolar macrophages.

Pharmacol Res. 1999; 39(1):41-47.

100. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK et al. Molecular

mechanisms underlying chemopreventive activities of anti-inflammatory

phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-

kappa B activation. Mutat Res. 2001; 481(5):243-68.

101. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA et al. Curcumin

blocks cytokine-mediated NF-kappa B activation and proinflammatory gene

expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999;

163(6):3474- 83.

102. Slater EP, Hesse H, Beato M. Regulation of transcription by steroide hormons. Ann.

Acad Science. 1994; 4(2):103-12.

103. Singh M, Pal M, Sharma RP. Biological activity of the labdane diterpenes. Planta

Med. 1999; 65(1):2-8.

104. Rasool M, Sabina EP. Antiinflammatory effect of the Indian ayurvedic herbal

formulation Triphala on adjuvant-induced arthritis in mice. Phytotherapy Research.

2007; 21(9):889-94.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 175

105. Pravin V, Gomase, Priti S. Shire, Nazim S, Amol B. Development and evaluation of

polyherbal formulation for anti-inflammatory activity. J Nat Prod Plant Resour. 2011;

1(1):85-90.

106. Himalaya Ayurvedic Gentle Face Wash Cream [Online] 2010 [cited 2010 April].

Available from: http://www matchless-gifts.com.

107. International Conference on Harmonization (ICH), Guidance for Industry, Q1A(R2):

Stability Testing of New Drug Substances and Products [Online] 2003 [cited 2003

Nov]. Available from: http://www.fda.gov/cber/gdlns/ichstab.pdf.

108. FDA, Draft Guidance for Industry, Stability Testing of Drug Substances and Drug

Products [Online] 1998 [cited 1998 June]. Available from

http://www.fda.gov/cber/gdlns/stabdft.pdf.

109. Sowbhagya HB, Smitha S, Sampathu SR, Krishnamurthy N, Bhattacharya S. Stability

of water-soluble turmeric colourant in an extruded food product during storage. J Food

Eng, 2005; 67(3):367-71.

110. Shrivastava SK, Rawat AS, Mehrotra S, Pushpangadan P. Botanical standardization of

three commercial important Curcuma species. J Sci Ind Reser. 2007 June; 66:450-56.

111. Khandelwal KR. Practical Pharmacognosy. Technique and experiments. 13th ed. Pune:

Nirali Prakashan; 2005. p. 157-60.

112. Kokate CK. Practical Pharmacognosy. 9th ed. Pune: Nirali Prakashan; 2002. p. 149-53.

113. Rajpal V. Standardization of botanicals. 2nd

ed. New Delhi: Business Horizons; 2011.

p. 1-5.

114. Mukherjee PK . Quality Control of Herbal Drugs- An Approach to Evaluation of

Botanicals. 1st ed. New Delhi: Business Horizons; 2002; p. 380.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 176

115. Handa SS, Sukhdev S. Khanuja SP, Dutt DR. Extraction Technologies for Medicinal

and Aromatic Plants. International centre for science and high technology Trieste,

[Online] 2008 [cited 2008 June]. Available from: http://www.unido.org/.

116. King MB, Bott TR, Extraction of natural products using near-critical solvents. 1st ed.

Bishopbriggs: Blackle academic professional an inprint of champan & hall; 1993. p.

140-56.

117. Finar IL, Finars Organic chemistry . Stereo Chemistry & the chemistry of Natural

Products. 5th ed. New Delhi: Dorling Kinbersley ltd; 2007.

118. OECD Guideline For Testing of Chemicals. Acute oral toxicity -Acute toxic Class

Method, 425, 2001. Annexure I. D, p 4.

119. Rispin A, Farrar D, Margosches E, Gupta K, Stitzel K, Carr G et al. Alternative

methods for the median lethal dose (LD 50) test: the up-and-down procedure for acute

oral toxicity. ILAR J. 2002; 43(4):233-43.

120. Syahmi AR, Vijayarathna S, Sasidharan S, Latha LY, 2, Kwan YP, Lau YL. Acute

oral toxicity and brine shrimp lethality of elaeis guineensis jacq., (oil palm leaf)

methanol extract. Molecules. 2010; 15(4):8111-21.

121. Butler SH, Godefroy F, Besson JM, Weil-Fugazza J. A limited arthritic model for

chronic pain studies in the rat. Pain. 1992; 48(1):73-81.

122. Dominique B, Jeanne WF, Lombard MC, Stephen H, Butler, Besson JM.

Monoarthritis induces complex changes in μ- δ- and κ-opioid binding sites in the

superficial dorsal horn of the rat spinal cord. European Journal of Pharmacology.

1992; 223(2):123-31.

123. Millecamps M, Jourdan D, Leger S, Etienne M, Eschalier A, Ardid D. Circadian

pattern of spontaneous behavior in monarthritic rats: a novel global approach to

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 177

evaluation of chronic pain and treatment effectiveness. Arthritis Rheum. 2005;

52(11):3470-8.

124. Chitme HR, Patel NP. Antiarthritis activity of Aristolochia bracteata extract in

experimental animals. Open Nature Product. 2009; 2:6-15.

125. De Castro Costa M, De Sutter P, Gybels J, Van Hees J. Adjuvant-induced arthritis in

rats: a possible animal model of chronic pain. Pain. 198; 10(2):173-85.

126. Kale SR, Kale RR. Practical Human Anatomy and Physiology. Pune: Nirali Prakashan;

1999.

127. Jain AK. Manual of Practical Physiology. New Delhi: Arya Publications; 1998. p. 22.

128. Mariappan G, Saha BP, Sutharson L, Singh A, Garg S, Pandey L et al. Analgesic,

anti-inflammatory, antipyretic and toxicological evaluation of some newer 3-methyl

pyrazolone derivatives. Saudi Pharm J. 2011; 19:115–22

129. Ramachandra SS, Quereshi AA, Viswanath Swamy AH, Patil T, Prakash T, Prabhu K

et al. Hepatoprotective activity of Calotropis procera flowers against paracetamol-

induced hepatic injury in rats. Fitoterapia. 2007; 78(7-8):451-54.

130. Dinesh M, Singh S, Joshi Y, Kadam V. Hepatoprotective activity of tuberous root of

Ipomoea digitata Linn against carbon tetrachloride induced hepatotoxicity. Int J

Pharma Sci Res. 2011; 2 (4):1034-39.

131. Kappor R, Kavimani S, Ravichandiran V, Sekhar K, Senthil R, Kumar M. Effect of

Indigofera aspalathoides on complete Freund’s adjuvant-induced arthritis in rats.

Pharm. Biol. 2009; 47(6):553-57.

132. Rej R, Vanderlinde RE. Assay of aspartate aminotransferase activity: effects of serum

and serum proteins on oxalacetate decarboxylation and dialysis. Clin Chem. 1974 Apr;

20(4):454-64.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 178

133. Parabathina RK, Muralinath E, Swamy LP, Hari VV, Krishna SK. Role of certain

flavonoids and vitamin-E against doxorubicin-induced oxiadative stress. J Chem

Pharm Res. 2011; 3(2):816-34.

134. Tietz N. Fundamentals of Clinical Chemistry. Philadelphia: WB Saunders Co; 1976.

135. Dipasquale G, Rassaert C, Welaj P, Gingold J, Schwartz E. Effects of multiple

treatments of isoxicam on organ weights and serum SGPT, AP, and BUN in adjuvant-

induced polyarthritic rats. Res Commun Chem Pathol Pharmacol. 1978; 19(3):529-32.

136. Harirforoosh S, Jamali F. Effect of inflammation on kidney function and

pharmacokinetics of COX-2 selective nonsteroidal anti-inflammatory drugs rofecoxib

and meloxicam. J Appl Toxicol. 2008; 28(7):829-38.

137. Young DS. Effects of Drugs on Clinical Laboratory Tests. 3rd ed. Philadelphia: WB

Saunders Co; 1990. p. 21-25.

138. Subramanian S. Diclofenac induced toxic manifestations on adjuvant-induced arthritic

rats pheripheral and reproductive organ of male wistar rats rattus norvegicus. J Toxicol

Environment Health Sci. 2009; 1(1):12-21.

139. Balis ME. Uric acid metabolism in man. Adv Clin Chem. 1976; 18:213-46

140. Trivedi R, Berta E, Rebar L. Enzymatic uric acid determination at 500nm by Trinder

method. Clin Chem. 1976; 22:1223.

141. Sanders GT, Pasman AJ, Hoek FJ. Determination of uric acid with uricase and

peroxidase. Clin Chim Acta. 1980; 101(2-3):299-303.

142. Shepherd MD, Mezzachi RD. Clinical chemistry principles and technics. Clin

Biochem Revs. 1983; 4(6):1-7.

143. Carlos A, Roncal, Wei M,

Byron C, Sirirat R, Xiaosen O. Effect of elevated serum uric

acid on cisplatin-induced acute renal failure. Am J of renal physiol. 2011; 301(1):42-

46.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 179

144. Browers LD. Text book of Clinical Chemistry. 3rd ed. Philadelphia: WB Sunders Co;

1980.

145. Bartel H. Serum creatinine determination without protein precipitation. Clin Chem

Acta. 1972; 37:193.

146. Arumugham R, Bose SM. Effect of Indomethacin and naproxen on the metabolism of

collagen in adjuvant-Induced Arthritis. J Rheumatol. 1981; 10(3):161-67.

147. Vijaya KN, Subramanian P. Protective effect of Semecarpus anacardium nut extract

against hyperammonemia in rats. J Herbal Med Toxicol. 2010; 4(2):77-82.

148. Total protein, Biuret method, end point. Erba diagnostic Mannheim GmbH kit,

Manufactured by Transasia Bio medicals LTD. Product code-FBCER0057.

149. Shirwaikar A, Somashekar AP, Udupa N, Udupa SL. Antiinflammatory activity and

free radical scavenging studies of Aristolochia bracteolate Lam. Ind J Pharma Sci.

2003; 65:67-9.

150. Fletcher DS, Widmer WR, Luell S, Christen A, Orevillo C, Shah S et al. Therapeutic

administration of a selective inhibitor of nitric oxide synthase does not ameliorate the

chronic inflammation and tissue damage associated with adjuvant-induced arthritis in

rats. J Pharmacol Exp Ther. 1998; 284(2):714-21.

151. Huskicl J, Zaciragic1 A, Babic N, Mulabegović N. Nitric oxide in serum and renal

tissue during compensatory renal hypertrophy in rats. Bosn J Basic Med Sci. 2006;

6(1):46-49.

152. Lam FF, Wong HH, Ng ES. Time course and substance P effects on the vascular and

morphological changes in adjuvant-induced monoarthritic rats. Int Immunopharmacol.

2004; 4(2):299-310.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 180

153. Demsar F, Van Dijke CF, Kirk BA, Kapila S, Peterfy CG, Roberts TP et al. Mapping

abnormal synovial vascular permeability in temporomandibular joint arthritis in the

rabbit using MRI. Br J Rheumatol. 1996; 35(3):23-5.

154. McDougall JJ, Karimian SM, Ferrell WR. Prolonged alteration of vasoconstrictor and

vasodilator responses in rat knee joints by adjuvant monoarthritis. Exp Physiol. 1995;

80(3):349-57.

155. Lam LY, Ferrell WR. Specific neurokinin receptors mediate plasma extravasation in

the rat knee joint. Br J Pharmacol. 199; 103(1): 1263-67.

156. Dimitrijević M, Laban O, Djurić VJ, Stanojević S, Miletić T, Kovacevic-Jovanović V

et al. Behavior and severity of adjuvant arthritis in four rat strains. Brain Behav

Immun. 2001; 15(3):255-65.

157. Sluka KA, Westlund KN. Behavioal and immunohistological changes in an

experimental arthritis model in rats. Pain. 1993; 55: 367-77.

158. Carlson RP, Datko LJ, Lynn ON, Frank D, Beideman R, Lewis AJ. Comparison of

inflammatory changes in established type-II collagen and adjuvant-induced arthritis

using outbred Wistar rats. Int J Immunopharmacol 1985; 7(6):811-26.

159. Chambon C, Paban V, Manrique C, Alescio-Lautier B. Behavioral and

immunohistological effects of cholinergic damage in immunolesioned rats: Alteration

of c-Fos and polysialylated neural cell adhesion molecule expression. Neuroscience.

2007;147(4):893-905.

160. Kulkarni SK. Hand book of experimental pharmacology. 3rd ed. New Delhi: Vallabh

prakashan; 2002. p. 128-31.

161. Bendele A, McAbee T, Sennello G, Frazier J, Chlipala E, McCabe D. Efficacy of

sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis:

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 181

comparison of efficacy in animal models with human clinical data. Arthritis

Rheum. 1999; 42(3): 498-506.

162. Severijnen AJ, Kleef R, Grandia AA, Kwast TH, Hazenberg MP. Histology of joint

inflammation induced in rats by cell wall fragments of the anaerobic intestinal

bacterium eubacterium aerofaciens. Rheumatol Int. 1991; 11(4-5):203-8.

163. Ekambaram S, Perumal SS, Subramanian V. Evaluation of antiarthritic activity of

Strychnos potatorum Linn seeds in Freund's adjuvant induced arthritic rat model.

Complement Altern Med. 2010; 13;10:56.

164. Hamada T, Arima N, Shindo M, Sugama K, Sasaguri Y. Suppression of adjuvant

arthritis of rats by a novel matrix metalloproteinase-inhibitor. Br J Pharmacol. 2000;

131(8):1513-20.

165. Department of Ayurveda, Yoga, & Naturopathy, Unani, Siddha and Homeopathy,

Ministry of health and Family Welfare, Government of India. Guidelines for Toxicity

Investigation of Herbal Medicine (Annexure-1) [Online] 2005 [cited 2005 Aug 19].

Available from: URL:http://indianmedecine.nic.in.

166. Popp T, Peddinghaus RM. Antirheumatic drug profiles evaluated in the adjuvant

arthritis of rats by multiparameter analysis. 1994; 42:50-5.

167. Bailey SA, Zidell RH, Perry RW. Relationships between organ weight and body/brain

weight in the rat: what is the best analytical endpoint. Toxicol Pathol. 2004; 32(4):448-

66.

168. Gepdiremen A, Mshvildadze V, Bakuridze K, Elias R. Effects of Leontice smirnowii

tuber monodesmosides and crude extract in carrageenan and histamine-induced acute

inflammation model of rats. Phytomedicine. 2006; 13(9-10):728-31.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 182

169. Vinegar R, Truax JF, Selph JL, Johnston PR, Venable AL, McKenzie KK. Pathway to

carrageenan-induced inflammation in the hind limb of the rat. Fed Proc. 1987;

46(1):118-26.

170. MacGlashan DJ. Histamine: A mediator of inflammation. J Allergy Clin

Immunol. 2003; 112(4):53-9.

171. Permin H, Skov PS, Norn S, Geisler A, Klysner R, Andersen V et al. Possible role of

histamine in rheumatoid arthritis, treatment with cimetidine and mepyramine.

Allergy. 1981; 36(6):435-36.

172. Huang M, Xie YY, Ding GH. Acupoint-injection of histamine induced analgesic effect

in acute adjuvant-induced-arthritis rats. Zhen Ci Yan Jiu. 2010; 35(2):99-103.

173. Asghari G, Mostajeran A, Shebli M. Curcuminoid and essential oil components of

turmeric at different stages of growth cultivated in Iran. Res Pharma Sci. 2009 April;

4(1):55-61.

174. Chearwae W, Wu CP, Chu HY, Lee TR, Ambudkar SV, Limtrakul P. Curcuminoids

purified from turmeric powder modulate the function of human multidrug resistance

protein 1 (ABCC1). Cancer Chemother Pharmacol. 2006; 57(3):376-88.

175. Brain. KR, Turner TD. The Practical evaluation of pharmaceuticals. 2nd ed. Bristol:

Wright scientechnica; 1975.

176. Stahl E. Thin Layer Chromatography - A laboratory Handbook. 2nd ed. New York:

Springer-Verlag Berlin Heidelberg; 1990.

177. Kasture AV, Wadodkar SG, Mahadik KR, More HN. A textbook of Pharmaceutical

analysis. (Instrumental methods). 2nd ed. Pune: Nirali Prakashan; 1997. p. 18-27.

178. Gupta AP, Gupta MM, Kumar S. Simultaneous determination of curcuminoids in

Curcuma samples using high performance thin layer chromatography. Liq. Chrom. &

Rel. Technol. 1999; 22(10):1561–69.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 183

179. Lou Y, Zhang H, He H, Peng K, Kang N, Wei X, et al. Isolation and identification of

phase 1 metabolites of curcumol in rats. Drug Metab Dispos. 2010; 38(11):2014-22.

180. Mara EM, Braga M, Angela A, Meireles. Accelerated solvent extraction and fractioned

extraction to obtain the Curcuma longa volatile oil and oleoresin. J Food Proce

Eng .2007; 30(4): 501–21.

181. Olga N, Pozharitskaya, Svetlana A, Ivanova, Alexander N, Shikov et al. Separation

and free radical-scavenging activity of major curcuminoids of Curcuma longa using

HPTLC-DPPH method. Phytochemical Analysis. 2008; 19(3): 236–43.

182. Katsuyama Y, Kita T, Horinouchi S. Identification and characterization of multiple

curcumin synthases from the herb Curcuma longa. FEBS Lett. 2009; 583(17):2799-

803.

183. Chearwae W, Anuchapreedac S, Nandigama K, Ambudkar SV, Limtrakul P.

Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by

curcumin I, II, and III purified from Turmeric powder. Bio Chem Pharm. 2004; 68(5):

2043–52.

184. Chethan KM. Turmerin, a protein from Curcuma longa L. prevent oxidative organ

damage against Naja naja venom phospholipase A2 in experimental animal. J Pharm

Clin Res. 2010; 3(1):29-34.

185. The Department of Health. British Pharmacopoeia. London: Health Ministry; 2008.

vol 2, p. 2360.

186. Mithal BM. Text book of Pharmaceutical Formulations. 6th ed. Delhi: Vallabh

Prakashan; 1997. p. 214.

187. Note for guidance on stability testing of new drug substance and products [Online]

2003 [cited 2003 Aug]. Available from:http://www emea.eu.int.

Chapter 8 Bibliography

Faculty of Pharmacy, Belgaum KLE University 184

188. Natalie Mc Clure, Matrix Pharmaceutical Inc. Stability studies an overview of ICH

guidelines for drug products [Online] 1957 [cited 1957 Oct 30]. Available from http://

www.mcclurenet.com.

189. Rainsford KD. Adjuvant polyarthritis in rats: is this a satisfactory model for screening

anti-arthritic drugs. Agents Actions. 1982; 12(4):452-8.

190. Patil KR, Patil CR, Jadhav RB, Mahajan VK, Patil PR, Gaikwad PS. Anti-arthritic

Activity of bartogenic acid isolated from fruits of Barringtonia racemosa Roxb.

(Lecythidaceae). Evid Based Complement Alternat Med. 2009 Sep 21.

191. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative

medicine use among adults: United States, 2002. Adv Data. 2004; (343):1-19.

192. Winter CA, Risley EA, Silber RH. Antiinflammatory activity of indomethacin and

plasma corticosterone in rats. J Pharmacol Exp Ther.1968; 162(1):196-201.